Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Eero Kaasinen, Hans Wijkström, Erkki Rintala, Oddvar Mestad, Staffan Jahnson & Per-Uno Malmström. (2016) Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder. Scandinavian Journal of Urology 50:5, pages 360-368.
Read now
Read now
Karsten Zieger & Klaus Møller-Ernst Jensen. (2011) Long-term risk of progression of carcinoma in situ of the bladder and impact of bacille Calmette–Guérin immunotherapy on the outcome. Scandinavian Journal of Urology and Nephrology 45:6, pages 411-418.
Read now
Read now
Alan R. Schned, Angeline S. Andrew, Carmen J. Marsit, Karl T. Kelsey, Michael S. Zens & Margaret R. Karagas. (2008) Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scandinavian Journal of Urology and Nephrology 42:3, pages 237-242.
Read now
Read now
M. William Murphy, Christer Busch & Ferran Algaba. (2000) Intraepithelial Lesions of Urinary Bladder: Morphologic Considerations. Scandinavian Journal of Urology and Nephrology 34:205, pages 67-81.
Read now
Read now
Sten Holmäng, Hans Hedelin, Claes Anderström, Erik Holmberg & Sonny L. Johansson. (2000) Prospective Registration of all Patients in a Geographical Region with Newly Diagnosed Bladder Carcinomas during a Two-year Period. Scandinavian Journal of Urology and Nephrology 34:2, pages 95-101.
Read now
Read now
Ebbe Kvist, Knud-Erik Sjølin, Jørgen Iversen & Kaare Nyholm. (1993) Urinary Excretion Patterns of Pseudouridine and β-Aminoisobutyric Acid in Patients with Tumours of the Urinary Bladder. Scandinavian Journal of Urology and Nephrology 27:1, pages 45-53.
Read now
Read now
Hans Wolf. (1991) Prognostic Factors in Bladder Carcinoma. Scandinavian Journal of Urology and Nephrology 25:sup138, pages 153-160.
Read now
Read now
Palle Rosenkilde Olsen, Hans Wolf, Torben Schroeder, Anders Fischer & Knud Højgaard. (1988) Urothelial Atypia and Survival Rate of 500 Unselected Patients with Primary Transitional-Cell Tumour of the Urinary Bladder. Scandinavian Journal of Urology and Nephrology 22:4, pages 257-263.
Read now
Read now
Articles from other publishers (22)
M. Varma, J.R. Srigley, F. Brimo, E. Compérat, B. Delahunt, M. Koch, A. Lopez-Beltran, V. Reuter, H. Samaratunga, J.H Shanks, T. Tsuzuki, T. van der Kwast, F. Webster & D. Grignon. (2020) Dataset for the reporting of urinary tract carcinoma—biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR). Modern Pathology 33:4, pages 700-712.
Crossref
Crossref
Karsten Zieger, Niels Marcussen, Michael Borre, Torben F. Ørntoft & Lars Dyrskjøt. (2009)
Consistent genomic alterations in carcinoma
in situ
of the urinary bladder confirm the presence of two major pathways in bladder cancer development
. International Journal of Cancer 125:9, pages 2095-2103.
Crossref
Crossref
Sandra R. Wolman, Bryan Goldman, Marilyn L. Slovak, Cathy Tangen, Diane L. Persons & David Wood. (2007) Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study. Cancer Genetics and Cytogenetics 176:1, pages 22-27.
Crossref
Crossref
Abolfazl Hosseini, Lotta Renström Koskela, Ingrid Ehrén, Miguel Aguilar-Santelises, Allan Sirsjö & N. Peter Wiklund. (2006) Enhanced formation of nitric oxide in bladder carcinoma in situ and in BCG treated bladder cancer. Nitric Oxide 15:4, pages 337-343.
Crossref
Crossref
. 2004. The Scientific Basis of Urology. The Scientific Basis of Urology
403
410
.
Eero Kaasinen, Hans Wijkström, Per-Uno Malmström, Sverker Hellsten, Milos Duchek, Oddvar Mestad & Erkki Rintala. (2003) Alternating Mitomycin C and BCG Instillations versus BCG Alone in Treatment of Carcinoma in Situ of the Urinary Bladder: A Nordic Study. European Urology 43:6, pages 637-645.
Crossref
Crossref
F Koenig. 2001. Handbook of Optical Coherence Tomography. Handbook of Optical Coherence Tomography
725
737
.
K. H. Kurth. (2014) Transurethrale Resektion von Blasentumoren. Der Urologe B 41:5, pages 501-511.
Crossref
Crossref
Peter W. Cooke, Nicholas D. James, Raji Ganesan, Michael Wallace, Andrea Burton & Lawrence S. Young. (1999) CD40 expression in bladder cancer. The Journal of Pathology 188:1, pages 38-43.
Crossref
Crossref
Zieger, Wolf, Olsen & HOjgaard. (1998) Long-term survival of patients with bladder tumours: the significance of risk factors. BJU International 82:5, pages 667-672.
Crossref
Crossref
Frank KoenigFrancis J. McGovernAlex F. AlthausenThomas F. DeutschKevin T. Schomacker. (1996) Laser Induced Autofluorescence Diagnosis of Bladder Cancer. Journal of Urology 156:5, pages 1597-1601.
Crossref
Crossref
L. A. L. M. KIEMENEY, J. A. WITJES, R. P. HEIJBROEK, N. P. KOPER, A. L. M. VERBEEK & F. M. J. DEBRUYNE. (2008) Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. British Journal of Urology 73:2, pages 164-171.
Crossref
Crossref
L.A.L.M. Kiemeney, J.A. Witjes, R.P. Heijbroek, F.M.J. Debruyne & A.L.M. Verbeek. (1994) Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer. European Journal of Cancer 30:11, pages 1621-1625.
Crossref
Crossref
H. Wolf. 1994. Tumours in Urology. Tumours in Urology
47
64
.
D. E. Neal. 1994. Tumours in Urology. Tumours in Urology
3
18
.
Niels C. Langkilde, Hans Wolf, Henrik Clausen, Thomas Kjeldsen & Torben F. Ørntoft. (1992) Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder. Relation to tumor recurrence and progression. Cancer 69:1, pages 219-227.
Crossref
Crossref
B. RICHARDS, M. K. B. PARMAR, C. K. ANDERSON, I. D. ANSELL, K. GRIGOR, R. R. HALL, A. R. MORLEY, F. K. MOSTOFI, R. A. RISDON & B. M. USCINSKA. (2008) Interpretation of Biopsies of “Normal” Urothelium in Patients with Superficial Bladder Cancer. British Journal of Urology 67:4, pages 369-375.
Crossref
Crossref
K. MELLON, D. E. NEAL, M. C. ROBINSON, C. MARSH & C. WRIGHT. (1990) Cell Cycling in Bladder Carcinoma Determined by Monoclonal Antibody Ki67. British Journal of Urology 66:3, pages 281-285.
Crossref
Crossref
E. Bezzi, L. Matturri, A. Mandressi & E. Pisani. (2018) Il Xxxvii Convegno Della Società Degli Urologi Del Nord Italia: Tavola Rotonda. I. Chemioterapia Neo-Adiuvante Del Carcinoma Della Vescica. Urologia Journal 57:2, pages 176-190.
Crossref
Crossref
David E. Neal, Linda Sharples, Kenneth Smith, Janet Fennelly, Reg R. Hall & Adrian L. Harris. (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:7, pages 1619-1625.
Crossref
Crossref
Karsten Nielsen, Torben ØRntoft & Hans Wolf. (1989) Stereologic estimates of nuclear volume in noninvasive bladder tumors (Ta) correlated with the recurrence pattern. Cancer 64:11, pages 2269-2274.
Crossref
Crossref
Niels Harving, Hans Wolf & Fleming Melsen. (1988) Positive Urinary Cytology After Tumor Resection: An Indicator for Concomitant Carcinoma in Situ. Journal of Urology 140:3, pages 495-497.
Crossref
Crossref